+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiopulmonary Bypass Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  • PDF Icon

    Report

  • 150 Pages
  • August 2023
  • Region: Global
  • DelveInsight
  • ID: 5863687

Cardiopulmonary Bypass Equipment Market By Product (Heart-Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography is expected to grow at a steady CAGR Forecast till 2028 owing to increasing prevalence of cardiovascular diseases and rising geriatric population.

The global cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2022, growing at a CAGR of 4.14% during the forecast period from 2023 to 2028, to reach USD 516.82 million by 2028. The demand for cardiopulmonary bypass equipment is primarily motivated by the increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter, and supraventricular tachycardia, decrease in heart muscle elasticity, decrease in heart output, rising burden of the geriatric population, increasing technological advancements and surge in product development activities among others during the forecast period.

Cardiopulmonary Bypass Equipment Market Dynamics:

According to World Health Organization (2022), approximately 17.9 million people die from cardiovascular diseases, which is an estimated 31% of all deaths worldwide. By 2030, around 23.6 million people are expected to die due to cardiovascular disorders. Thus, the number of surgeries for cardiovascular diseases is increasing, requiring cardiopulmonary bypass (CPB), which provides a bloodless field for cardiac surgery. The advancement in cardiac surgery has been possible due to the development of cardiopulmonary bypass.

As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure of such patients is expected to double and reach 1.5 billion by 2050. With increasing age, the risk for cardiovascular diseases and the need for cardiac surgeries also increases and will thereby assist in the growth of cardiopulmonary bypass equipment.

Moreover, companies are increasing their research and development to develop products that have better efficacy and are easy to operate. For example, in October 2020, Abiomed announced that its compact cardiopulmonary bypass system, Breethe OXY-1, received 510(k) clearance from the FDA.

Thus, all these factors are projected to drive the growth of the market for cardiopulmonary bypass equipment.

Certain factors such as the high cost of cardiac surgery and risk of failure during the surgery and strict regulations by regulatory bodies pose a minor hurdle to the growth of the market.

Cardiopulmonary Bypass Equipment Market Segment Analysis:

Cardiopulmonary Bypass Equipment Market By Product (Heart-Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type of devices segment, heart-lung machines are expected to hold the largest share in the market as cardiopulmonary bypass equipment. This is attributed to the advantages and applications associated with heart-lung machines.

Heart-Lung Machines are an important tool required during any cardiopulmonary surgery. An artificial heart-lung machine is used in open-heart surgeries to support the proper functioning of the heart and body during the surgery.

The heart-lung machine consists of a chamber that receives blood from the body, oxygenates the blood, and transfers it to all parts of the body. This machine is connected to the patient with a series of tubes, which are removed after the completion of the surgery when the heart and lungs resume their functions.

The increase in the prevalence of heart disease, a growing aging population who are very susceptible to coronary heart disease and pulmonary diseases, technological developments in artificially managing the organs that minimize the burden on the heart and lungs during surgery, and improved efficiency of devices are some of the other factors assisting in the growing demand for heart-lung machines.

Additionally, assistance from government bodies, in equipping new/existing hospitals and healthcare centers in rural regions, is expected to enhance the market potential in several countries.

Hence, all the above-mentioned factors are expected to drive the segment growth.

North America is expected to dominate the overall Cardiopulmonary Bypass Equipment Market:

North America is expected to dominate the overall cardiopulmonary bypass equipment market during the forecast period. This domination is due to the growing number of individuals with cardiopulmonary and other chronic diseases, changing lifestyles, rising geriatric population, presence of key players, increasing product development activities in the region, and others during the forecast period.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.

Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent - the damage is done, but the person is not aware of it.

This situation is giving rise to a critical need for cardiopulmonary bypass equipment for the diagnosis, prevention, and treatment of the disease.

The increasing number of product development activities in the region is further going to accelerate the growth of the cardiopulmonary bypass equipment market. For example, in March 2023 the US Food and Drug Administration (FDA) granted 510(k) clearance to LivaNova's Essenz heart-lung machine (HLM) for use in cardiopulmonary bypass (CPB) procedures.

Cardiopulmonary Bypass Equipment Key Players:

Some of the key market players operating in the cardiopulmonary bypass equipment market include Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.

Recent Developmental Activities in Cardiopulmonary Bypass Equipment:

  • In August 2022, FDA awarded the breakthrough privileges to Abiomed's Impella ECP expandable percutaneous heart pump.
  • In April 2022, LivaNova received FDA 510(k) clearance for its B-Capta system integrated into the S5 heart-lung machine.
  • In October 2020, Abiomed received FDA 510(k) clearance for an all-in-one, compact extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System.

Key Takeaways from the Cardiopulmonary Bypass Equipment Market Report Study

  • Market size analysis for current market size (2022), and market forecast for 5 years (2023-2028)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global cardiopulmonary bypass equipment market.
  • Various opportunities available for the other competitor in the cardiopulmonary bypass equipment market space.
  • What are the top-performing segments in 2022? How these segments will perform in 2028?
  • Which are the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from this Cardiopulmonary Bypass Equipment Market Report Study

  • Cardiopulmonary Bypass Equipment providers
  • Research organizations and consulting companies
  • Cardiopulmonary Bypass Equipment-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders
  • Various End-users who want to know more about the cardiopulmonary bypass equipment market and the latest technological developments in the cardiopulmonary bypass equipment market.

Frequently Asked Questions for Cardiopulmonary Bypass Equipment Market:

1. What is Cardiopulmonary Bypass Equipment?

Cardiopulmonary bypass (CPB) equipment provides a bloodless field for cardiac surgery and does the work of both the heart (i.e., pumps blood) and the lungs (i.e., oxygenates the blood). CPB circuit includes pumps, cannulae, tubing, reservoir, oxygenator, heat exchanger, and arterial line filter. Cardiopulmonary bypass machines are operated by perfusionists to bypass the heart and lungs during open-heart surgery.

2. What is the market for global cardiopulmonary bypass equipment?

The global cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2022, growing at a CAGR of 4.14% during the forecast period from 2023 to 2028, to reach USD 516.82 million by 2028.

3. What are the drivers for the cardiopulmonary bypass equipment market?

The major drivers driving the demand for cardiopulmonary bypass equipment are the increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter and supraventricular tachycardia, a decrease in heart muscle elasticity, a rising geriatric population, increasing technological advancements, and a surge in product development activities among others.

4. Who are the key players operating in the global cardiopulmonary bypass equipment market?

Some of the key market players operating in the cardiopulmonary bypass equipment market include Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.

5. Which region has the highest share in the cardiopulmonary bypass equipment market?

North America is expected to dominate the overall cardiopulmonary bypass equipment market during the forecast period, 2023 to 2028. This domination is due to the growing number of cardiac surgeries, demand for advanced technologies in cardiopulmonary bypass equipment, and rise in healthcare expenditure by the US government among others.



This product will be delivered within 3-5 business days.

Table of Contents

1. Cardiopulmonary Bypass Equipment Market Report Introduction
2. Cardiopulmonary Bypass Equipment Executive Summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Cardiopulmonary Bypass Equipment Market Key Factors Analysis
4.1. Cardiopulmonary Bypass Equipment Market Drivers
4.1.1. Increase in the prevalence of cardiovascular diseases and respiratory diseases
4.1.2. Increasing number of surgical procedures
4.1.3. Rising burden of cardiovascular diseases
4.1.4. Rising geriatric population
4.2. Cardiopulmonary Bypass Equipment Market Restraints and Challenges
4.2.1. High cost of cardiac surgery and risk of failure during the surgery
4.2.2. Strict regulations by regulatory bodies
4.3. Cardiopulmonary Bypass Equipment Market Opportunities
4.3.1. Growing demand for minimal invasive surgery
4.3.2. Growing demand for Cardiopulmonary Bypass Equipment in non-hospital settings
5. Cardiopulmonary Bypass Equipment Porter's Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. Cardiopulmonary Bypass Equipment Market Layout
6.1. By Product
6.1.1. Heart-Lung Machines
6.1.2. Oxygenators
6.1.3. Autotransfusion Systems
6.1.4. Others
6.2. By Application
6.2.1. Cardiovascular
6.2.2. Respiratory
6.2.3. Hemodialysis
6.2.4. Others
6.3. By End-User
6.3.1. Hospitals
6.3.2. Specialty Clinics
6.3.3. Dialysis Centers
6.3.4. Ambulatory Surgery Centers
6.4. By Geography
6.4.1. North America Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.1.1. United States Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.1.2. Canada Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.1.3. Mexico Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2. Europe Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.1. France Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.2. Germany Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.3. United Kingdom Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.4. Italy Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.5. Spain Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.2.6. Rest of Europe Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3. Asia-Pacific Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.1. China Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.2. Japan Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.3. India Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.4. Australia Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.5. South Korea Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.3.6. Rest of Asia-Pacific Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.4. Rest of the World (RoW) Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.4.1. Middle East Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.4.2. Africa Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
6.4.4.3. South America Cardiopulmonary Bypass Equipment Market Size in USD million (2020-2028)
7. Cardiopulmonary Bypass Equipment Company and Product Profiles
7.1. Medtronic
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Financial Overview
7.1.4. Product Listing
7.1.5. Entropy
7.2. LivaNova PLC
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Financial Overview
7.2.4. Product Listing
7.2.5. Entropy
7.3. MAQUET Holding B.V. & Co. KG.
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Financial Overview
7.3.4. Product Listing
7.3.5. Entropy
7.4. ABIOMED
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Financial Overview
7.4.4. Product Listing
7.4.5. Entropy
7.5. Braile Biomedica Ltda
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Financial Overview
7.5.4. Product Listing
7.5.5. Entropy
7.6. Tianjin Medical
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Financial Overview
7.6.4. Product Listing
7.6.5. Entropy
7.7. Terumo Corp
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Financial Overview
7.7.4. Product Listing
7.7.5. Entropy
7.8. Senko Medical Instrument Manufacturing Co.,Ltd.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Financial Overview
7.8.4. Product Listing
7.8.5. Entropy
7.9. Technowood Corp
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Financial Overview
7.9.4. Product Listing
7.9.5. Entropy
7.10. Sorin
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Financial Overview
7.10.4. Product Listing
7.10.5. Entropy
7.11. MicroPort Scientific Corporation
7.11.1. Company Overview
7.11.2. Company Snapshot
7.11.3. Financial Overview
7.11.4. Product Listing
7.11.5. Entropy
7.12. Xenios AG
7.12.1. Company Overview
7.12.2. Company Snapshot
7.12.3. Financial Overview
7.12.4. Product Listing
7.12.5. Entropy
7.13. Nipro Corporation
7.13.1. Company Overview
7.13.2. Company Snapshot
7.13.3. Financial Overview
7.13.4. Product Listing
7.13.5. Entropy
7.14. OriGen Biomedical
7.14.1. Company Overview
7.14.2. Company Snapshot
7.14.3. Financial Overview
7.14.4. Product Listing
7.14.5. Entropy
7.15. Thoratec Corporation
7.15.1. Company Overview
7.15.2. Company Snapshot
7.15.3. Financial Overview
7.15.4. Product Listing
7.15.5. Entropy
8. KOL Views9. Project Approach10. Publisher Capabilities11. About the Publisher12. Disclaimer & Contact the Publisher
List of Tables
Table 1: Competitive Analysis
Table 2: Cardiopulmonary Bypass Equipment Market in Global (2020-2028)
Table 3: Cardiopulmonary Bypass Equipment Market in Global by Product (2020-2028)
Table 4: Cardiopulmonary Bypass Equipment Market in Global by Application (2020-2028)
Table 5: Cardiopulmonary Bypass Equipment Market in Global by End-User (2020-2028)
Table 6: Cardiopulmonary Bypass Equipment Market in Global by Geography (2020-2028)
Table 7: Cardiopulmonary Bypass Equipment Market in North America (2020-2028)
Table 8: Cardiopulmonary Bypass Equipment Market in the US (2020-2028)
Table 9: Cardiopulmonary Bypass Equipment Market in Canada (2020-2028)
Table 10: Cardiopulmonary Bypass Equipment Market in Mexico (2020-2028)
Table 11: Cardiopulmonary Bypass Equipment Market in Europe (2020-2028)
Table 12: Cardiopulmonary Bypass Equipment Market in France (2020-2028)
Table 13: Cardiopulmonary Bypass Equipment Market in Germany (2020-2028)
Table 14: Cardiopulmonary Bypass Equipment Market in the United Kingdom (2020-2028)
Table 15: Cardiopulmonary Bypass Equipment Market in Italy (2020-2028)
Table 16: Cardiopulmonary Bypass Equipment Market in Spain (2020-2028)
Table 17: Cardiopulmonary Bypass Equipment Market in Rest of Europe (2020-2028)
Table 18: Cardiopulmonary Bypass Equipment Market in Asia-Pacific (2020-2028)
Table 19: Cardiopulmonary Bypass Equipment Market in China (2020-2028)
Table 20: Cardiopulmonary Bypass Equipment Market in Japan (2020-2028)
Table 21: Cardiopulmonary Bypass Equipment Market in India (2020-2028)
Table 22: Cardiopulmonary Bypass Equipment Market in Australia (2020-2028)
Table 23: Cardiopulmonary Bypass Equipment Market in South Korea (2020-2028)
Table 24: Cardiopulmonary Bypass Equipment Market in Rest of Asia-Pacific (2020-2028)
Table 25: Cardiopulmonary Bypass Equipment Market in the Rest of the World (2020-2028)
Table 26: Cardiopulmonary Bypass Equipment Market in the Middle East (2020-2028)
Table 27: Cardiopulmonary Bypass Equipment Market in Africa (2020-2028)
Table 28: Cardiopulmonary Bypass Equipment Market in South America (2020-2028)
List of Figures
Figure 1: Competitive Analysis
Figure 2: Cardiopulmonary Bypass Equipment Market in Global (2020-2028)
Figure 3: Cardiopulmonary Bypass Equipment Market in Global by Product (2020-2028)
Figure 4: Cardiopulmonary Bypass Equipment Market in Global by Application (2020-2028)
Figure 5: Cardiopulmonary Bypass Equipment Market in Global by End-User (2020-2028)
Figure 6: Cardiopulmonary Bypass Equipment Market in Global by Geography (2020-2028)
Figure 7: Cardiopulmonary Bypass Equipment Market in North America (2020-2028)
Figure 8: Cardiopulmonary Bypass Equipment Market in the US (2020-2028)
Figure 9: Cardiopulmonary Bypass Equipment Market in Canada (2020-2028)
Figure 10: Cardiopulmonary Bypass Equipment Market in Mexico (2020-2028)
Figure 11: Cardiopulmonary Bypass Equipment Market in Europe (2020-2028)
Figure 12: Cardiopulmonary Bypass Equipment Market in France (2020-2028)
Figure 13: Cardiopulmonary Bypass Equipment Market in Germany (2020-2028)
Figure 14: Cardiopulmonary Bypass Equipment Market in the United Kingdom (2020-2028)
Figure 15: Cardiopulmonary Bypass Equipment Market in Italy (2020-2028)
Figure 16: Cardiopulmonary Bypass Equipment Market in Spain (2020-2028)
Figure 17: Cardiopulmonary Bypass Equipment Market in Rest of Europe (2020-2028)
Figure 18: Cardiopulmonary Bypass Equipment Market in Asia-Pacific (2020-2028)
Figure 19: Cardiopulmonary Bypass Equipment Market in China (2020-2028)
Figure 20: Cardiopulmonary Bypass Equipment Market in Japan (2020-2028)
Figure 21: Cardiopulmonary Bypass Equipment Market in India (2020-2028)
Figure 22: Cardiopulmonary Bypass Equipment Market in Australia (2020-2028)
Figure 23: Cardiopulmonary Bypass Equipment Market in South Korea (2020-2028)
Figure 24: Cardiopulmonary Bypass Equipment Market in Rest of Asia-Pacific (2020-2028)
Figure 25: Cardiopulmonary Bypass Equipment Market in the Rest of the World (2020-2028)
Figure 26: Cardiopulmonary Bypass Equipment Market in the Middle East (2020-2028)
Figure 27: Cardiopulmonary Bypass Equipment Market in Africa (2020-2028)
Figure 28: Cardiopulmonary Bypass Equipment Market in South America (2020-2028)
Figure 29: Market Drivers
Figure 30: Market Barriers
Figure 31: Market Opportunities
Figure 32: PORTER'S Five Force Analysis

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • Terumo Corporation
  • Braile Biomedica
  • Tianjin Medical
  • Senko Medical Instrument Manufacturing